The Effect of Injury Severity on Behavior: a Phenotypic Study of Cognitive and Emotional Deficits After Mild, Moderate, and Severe Controlled Cortical Impact Injury in Mice
Overview
Neurology
Authors
Affiliations
Traumatic brain injury (TBI) can cause a broad array of behavioral problems including cognitive and emotional deficits. Human studies comparing neurobehavioral outcomes after TBI suggest that cognitive impairments increase with injury severity, but emotional problems such as anxiety and depression do not. To determine whether cognitive and emotional impairments increase as a function of injury severity we exposed mice to sham, mild, moderate, or severe controlled cortical impact (CCI) and evaluated performance on a variety of neurobehavioral tests in the same animals before assessing lesion volume as a histological measure of injury severity. Increasing cortical impact depth successfully produced lesions of increasing severity in our model. We found that cognitive impairments in the Morris water maze increased with injury severity, as did the degree of contralateral torso flexion, a measure of unilateral striatal damage. TBI also caused deficits in emotional behavior as quantified in the forced swim test, elevated-plus maze, and prepulse inhibition of acoustic startle, but these deficits were not dependent on injury severity. Stepwise regression analyses revealed that Morris water maze performance and torso flexion predicted the majority of the variability in lesion volume. In summary, we find that cognitive deficits increase in relation to injury severity, but emotional deficits do not. Our data suggest that the threshold for emotional changes after experimental TBI is low, with no variation in behavioral deficits seen between mild and severe brain injury.
Svirsky S, Henchir J, Parry M, Holets E, Zhang T, Gittes G Sci Rep. 2024; 14(1):28998.
PMID: 39578516 PMC: 11584851. DOI: 10.1038/s41598-024-77682-2.
Imaging the large-scale and cellular response to focal traumatic brain injury in mouse neocortex.
Bibineyshvili Y, Vajtay T, Salsabilian S, Fliss N, Suvarnakar A, Fang J Exp Physiol. 2024; 110(2):321-344.
PMID: 39576175 PMC: 11782206. DOI: 10.1113/EP092219.
Khan T, Hussain A, Casilli T, Frayser L, Cho M, Williams G Aging Cell. 2024; 23(9):e14239.
PMID: 39031751 PMC: 11488304. DOI: 10.1111/acel.14239.
Ahmed M, Suhail H, Nematullah M, Hoda M, Giri S, Ahmad A bioRxiv. 2024; .
PMID: 38979231 PMC: 11230198. DOI: 10.1101/2024.06.25.600422.
Modulation of microglia activation by the ascorbic acid transporter SVCT2.
Marino A, Rex T, Harrison F Brain Behav Immun. 2024; 120:557-570.
PMID: 38972487 PMC: 11458066. DOI: 10.1016/j.bbi.2024.07.003.